Global Survey Suggests RCC Patients Are Underinformed, Face Obstacles to Care
Results of a global survey highlight areas for improvement in the care of patients with renal cell carcinoma.
Results of a global survey highlight areas for improvement in the care of patients with renal cell carcinoma.
Researchers sought to determine the predictive value of mean platelet volume as a marker for cancer outcomes.
Avelumab plus cabozantinib has shown preliminary clinical activity and an acceptable safety profile in metastatic clear cell RCC, according to researchers.
Blood type may impact immunotherapy outcomes in patients with metastatic RCC, a study suggests.
Genomic screening for Lynch syndrome, hereditary breast and ovarian cancer syndrome, and familial hypercholesterolemia likely cost-effective for adults younger than 40 years
With effective modern systemic therapies for metastatic RCC, how cytoreductive nephrectomy affects quality of life has become an increasingly relevant question, according to investigators.
Patients undergoing the operation in 2015-2019 vs 2005-2009 are less likely to have major surgical complications or die within 90 days, according to a study.
No residual malignancy was found in 98% of patients treated with percutaneous cryoablation.
ALLO-316 has shown activity in a phase 1 study of patients with heavily pretreated, advanced clear cell renal cell carcinoma.
Combination treatment with belzutifan and cabozantinib has demonstrated antitumor activity in previously treated, advanced clear cell renal cell carcinoma.